BioCentury
ARTICLE | Company News

Sinclair, Solvay sales and marketing update

October 19, 2009 7:00 AM UTC

Sinclair will acquire worldwide rights, excluding the U.K. and Italy, to Flammazine and Flammacerium from Solvay for €17.5 million ($25.7 million). The silver sulfadiazine topical creams are markete...